» Registration 9:00am - 10:30am

• » [+] Inaugural Sessions

  » [-] Inaugural Sessions

  Session	Speaker	Time
  Inaugural Sessions                                               10.30am - 12.30pm
  Welcome Address	Mr. Jasu Shah Chairman, Chemtech Foundation
  Special Address by the Chairman Opportunities & Challenges of the Pharma industry	Mr.Ranjit Shahani Vice Chairman & MD Novartis India Ltd
  Keynote Address Indian Pharmaceutical Industry on a Higher Growth Trajectory	Dr.Reinhardt Glueck CSO,Zydus Cadilla, President-Swiss Biotech Association, Ahmedabad
  Lunch break:	12:30pm - 2:00pm

• » [+] Sessions I

  » [-] Sessions I

  Session	Speaker	Time
  Advances in Pharmaceutical Research                 2:00pm - 3:30pm
  Session Chairman	Dr. Ajit Dangi President & CEO, Danssen Consulting
  Advances in stem cell Research	Dr. Ramanand Nadig CEO, Khoday Stem Cell Research & Medical Centre	2:10 – 2:30
  Micro fluidics Enables Small-Scale Tissue-Based Metabolism Studies with Scarce Human Tissue	Mr. Paul van Midwoud University of Groningen	2:30 – 2:50
  Using Nanotechnology for Drug Delivery	Mr.Andy Zaayenga Board secretary SLAS	2:50 – 3:10
  Always on Automation-An Emerging Paradigm for Flexible Automated Systems in Laboratory Research	Dr. Jay Gill Bristol-Myers Squibb SLAS	3:10 - 3:30
  Q&A		3:30 - 3:40
  Tea / Coffee Break		3:40 - 4:00

• » [+] Sessions II

  » [-] Sessions II

  Session	Speaker	Time
  Advances in Pharmaceutical Research(Continued) 4:00pm – 5:20pm
  Session Chairman	Mr.Mahesh Malneedi President,Makrocare
  An Introduction to SLAS and Laboratory Technology Trends	Mr.Steve Hamilton Director of Education, SLAS	4:10 – 4:30
  Laboratory Equipment - Evolution from manual experimentation on the bench to laboratory automation workcell.	Mr.Malcolm Crook LAS Executive Council President - PAA SLAS	4:30 - 4:50
  Advances and Trends in Biopharmaceutical Manufacturing Facility Design	Ms.Roshni Dutton BioProcess Expert SNC-Lavalin Pharma, Toronto, Ontario, Canada	4:50 – 5:10
  University of North Carolina SLAS	Mr.Bill Janzen Kinase Drug Discovery at UNC	5:10 – 5:30
  Q&A		5:30 - 5:40


Day II - February 25, 2011



• » [+] Sessions III

  » [-] Sessions III

  Session	Speaker	Time
  Future Trends & Opportunities                            10:00am - 11:25am
  Session Chairman	Dr.Devindra Pal President & CEO, Catalyst Pharma Consulting
  Trends in Graduate Life Sciences Education in the U.S.	Dr.Jim Sterling VP Keck Graduate Institute	10:10– 10:30
  Managing Intellectual Property as a competitive Strategy	Dr.Ajit Dangi President & CEO Danssen Consulting	10:30-10:50
  Challenges emitting from globalisation & patient safety	Mr.Praful Naik CSO Bilcare	10:50-11:10
  Sustainability and the Manufacturing Environment	Dr. Peter Carvalho Siemens AG, Engineering & Consulting	11:10 - 11:30
  Q&A		11:30 - 11:40
  Tea / Coffee Break		11:40 - 12:00

• » [+] Sessions IV

  » [-] Sessions IV

  Session	Speaker	Time
  Achieving Excellence Through Innovation          11:40am - 1:20pm
  Session Chairman	Mr.Shakti Chakrovarty, President-Domestic Pharma Business, Lupin Ltd.
  Panel members:	Mr. K Shivkumar Director – Pharma Merck Ltd.
  Moving from Cost Arbitrage to Intellectual Arbitrage in Pharmaceutical Outsourcing	Dr. Prabuddha Ganguli CEO VISION-IPR	12:10 -12:30
  Evolution of HTS as the key lead identification tool in drug discovery	Dr.Jeff Paslay Director SLAS	12:30 - 12:50
  Sustainable production of platform chemicals based on renewable feedstock	Dr. Kurt Wagemann CEO DECHEMA	12:50 – 1:10
  Q&A		1:10 – 1:20
  Lunch break		1:20 - 2:00

• » [+] Sessions V

  » [-] Sessions V

  Session	Speaker	Time
  Improving Access to Medicines                            2:00pm - 3:40pm
  Session Chairman	Mr.Anirban Roy Head Social Marketing -Arogya Parivar, Novartis India Ltd.
  Pharmaco-economics for improved healthcare outcomes in India	Dr.Gopakumar Nair MD Gopakumar Nair Associates	2:10 - 2:30
  Access to Medicines in clinical trials	Ms.Jeroze Dalal Head-Clinical Operations Glaxo Smith Kline Pharmaceuticals Ltd.	2:30 – 2:50
  Affordable Healthcare	Mr.Daara Patel Secretary General IDMA	2:50 – 3:10
  Q&A		3:10 – 3:20
  Tea / Coffee Break		3:20 - 3:45

• » [+] Sessions VI

  » [-] Sessions VI

  Session	Speaker	Time
  Making India Destination of choice for Clinical Research 4:00pm – 5:40pm
  Session Chairman	Dr. Shrikant Sapatnekar Medical Director & COO, Karmic Lifesciences Pvt. Ltd.
  Panel members:	Mr. Jagadish Kumar Vice President – Business Development, Reliance Life sciences Ltd.
  Newer Designs in Clinical Research	Dr.Arun Bhatt President, CLINinvent	3:45 – 4:05
  Managing risks of clinical trials	Dr.Sonal Vora Founder & Director, SYNERGETIK Learning Solutions	4:05 - 4:25
  Harmonising regulatory practices for clinical trials	Dr Kiran Marthak Director, Veeda Clinical Research	4:25 – 4:45
  Clinical Development Opportunities in India	Dr. Yashesh Mehta Senior Director, Operations inVentiv International Pharma Services (IIPS)	4:45 – 5:05
  Q&A		5:05 - 5:15

* Confirmation Awaited